An observational study in Obesity, Morbid and Bariatric Surgery Candidate, sponsored by University of California, Davis. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-12-05.
Sponsored by University of California, Davis · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 213 studies in Obesity, Morbid with a site in United States — 28 open to participants now, 36 under way, 1 of them phase 3. Obesity, Morbid · United States.
Among the 213 studies in Obesity, Morbid with a site in United States, this one has the largest planned enrollment of the 63 observational ones that give a count, is one of 10 that started in 2022, is one of 63 observational ones, reaches primary completion later than 11 of the 34 other live ones, and was the 179th registered.
941 studies on the registry are indexed under Obesity, Morbid; 162 are open to participants now.
Browse Obesity, Morbid studies →28 of the 213 studies in Obesity, Morbid with a site in United States are open now. Recruiting first, the newest first:
Christopher C. Thompson, MD, MSc · Sites in United States
Ages 18–90
The Cleveland Clinic · Sites in United States
Ages 18–70
University of Maryland, Baltimore · Sites in United States
Ages 18+ · Women only
University of Missouri-Columbia · Sites in United States
Ages 18+
Salvador Navarrete · Sites in United States
Ages 18–70
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 109 Obesity, Morbid studies recruiting now, 21 (19%) set no upper age limit and 83 (76%) stop at 75 or younger; 8 take children under 18; 9 take healthy volunteers.
This study: 18 Years to 75 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
213 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 13 · Phase 2 11 · Phase 3 8 · Phase 4 13
First in 1980; this study’s year is marked. 10 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 9,500 is above the median of 80 across 311 observational studies indexed under Obesity, Morbid.
Median enrollment 39 across the 150 interventional studies, 50 across the 63 observational. Of the 147 that completed or were terminated, 56 (38%) have results posted.
This tab as a report to print or save as PDF → With an account.
22 of 213 have an industry lead sponsor. The 10 most frequent:
University of California, Davis is the lead sponsor of 811 studies on the registry; 141 are open to participants now.
Of its 67 completed or terminated interventional studies of FDA-regulated products, 43 (64%) have results posted.
University of California, Davis has 4 studies filed under Obesity, Morbid — fewer than ten, so there is no comparison to draw.
8 of the studies in Obesity, Morbid with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06199154University of Maryland, BaltimoreInduction of Labor in Morbidly Obese Patients | 2026-12 |
| NCT05711758Christopher C. Thompson, MD, MScEfficacy and Safety of Endoscopic Antral Myotomy as a Novel Weight Loss Procedure | 2026-12 |
| NCT02602769Columbia UniversityWhole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome | 2026-12 |
| NCT05215886University of California, DavisCognitive Impairment, Obesity, and the Effects of Bariatric Surgery | 2026-12-31 |
| NCT03868592Mayo ClinicLong-term, Substantial Weight Loss and Insulin Regulation of Lipolysis | 2027-05 |
Add all 8 to your calendar (.ics) → With an account.
Among the 213 studies in Obesity, Morbid with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Study is designed to screen psychological cognitive baseline and retention/improvement after weight loss surgery.
Patients with morbid obesity have shown to be at increased risk for memory loss and cognitive decline. Obesity and high-fat diets have been associated with deficits in learning, memory, and executive functioning. Bariatric surgery results in significant weight loss for patients and helps resolve obesity-related comorbidities such as diabetes and high blood pressure. Interestingly, bariatric surgery has shown promise in improving some aspects of cognitive function and improved memory. (3-1) Obesity affects brain structure, more specifically the grey and white matter, likely in part by reducing oxygen flow to the various regions in the brain. Studies have shown a correlation between BMI and cerebral blood flow velocity (CBFV), where higher BMI is associated with lower CBFV. Although it is not clear how exactly obesity plays a role in the brain's structural and functional changes, observations revealed compromised grey and white matter integrity, its fiber connectivity or cortical atrophy and metabolic alterations. (2)
Few studies exist on the impact of bariatric surgery on cognition. Some studies have shown that patients with obesity who underwent bariatric surgery had memory and cognitive improvement compared to those who had not undergone surgery. (4) Thus, the investigators hope to add to our understanding of how bariatric surgery can improve cognitive decline and to potentially offer surgery to more patients with baseline cognitive impairment and to improve cognitive function overall for patients with obesity. More longitudinal studies need to be done to connect bariatric surgery effects with cognitive decline, specifically memory.
Subjects seeking weight loss surgery or with a history of weight loss surgery at University of California Davis Medical Center 18 years of age or older
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients without a history of memory impairment/loss, bariatric surgery, or obesity
Patients scheduled for or have already completed Weight Loss Surgery at UC Davis Medical Center
Behavioral: Surgery
Study subjects scheduled for or have already completed weight loss surgery and have already completed psychological screening as part of their pre-surgery work up
California Verbal Learning Test-3rd Edition (CVLT-3)
Measures episodic verbal learning including Verbal Learning, immediate memory, and delayed memory
Time frame: Pre-operatively
California Verbal Learning Test-3rd Edition (CVLT-3)
Measures episodic verbal learning including Verbal Learning, immediate memory, and delayed memory
Time frame: 12 Months after index screening/date of surgery
Brief Visuospatial Memory Test
Measures visuospatial learning and memory, including visual learning, immediate memory, and delayed memory.
Time frame: Pre-operatively and 12 months after index screening/date of surgery
Brief Visuospatial Memory Test
Measures visuospatial learning and memory, including visual learning, immediate memory, and delayed memory.
Time frame: Pre-operatively
Trial Making Test, A & B
Measures visual spatial attention, motor speed and cognitive flexibility
Time frame: 12 months after index screening/date of surgery
WAIS-IV Digit Span Forward & Backward
Measures auditory Attention (Forward), and Auditory attention and working memory (Backward)
Time frame: Pre-Operatively
WAIS-IV Digit Span Forward & Backward
Measures auditory Attention (Forward), and Auditory attention and working memory (Backward)
Time frame: 12 months after Index screening/date of surgery
Verbal Fluency, Phonemic & Semantic
Measures verbal fluency by a word generation task based on letter \& category (executive functioning)
Time frame: Pre-operatively
Verbal Fluency, Phonemic & Semantic
Measures verbal fluency by a word generation task based on letter \& category (executive functioning)
Time frame: 12 months after index screening/date of surgery
Stroop Color and Word Test; Word, Color & Word-Color
Measures reading speed (word), naming speed (processing) and selective attention and inhibition (attention/executive functioning)
Time frame: Pre-Operatively
Stroop Color and Word Test; Word, Color & Word-Color
Measures reading speed (word), naming speed (processing) and selective attention and inhibition (attention/executive functioning)
Time frame: 12 months after index screening/date of surgery
Plan to share: Undecided — No plan in place (yet) for data sharing
Started Jan 2022 (actual). Primary completion is estimated for Dec 2026, 59 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of California, Davis →